WEC
PACB icon

Winslow Evans & Crocker’s Pacific Biosciences PACB Stock Holding History

Winslow Evans & Crocker’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$20K Hold
770
– – ﹤0.01% 790
2020
Q3 		$8K Hold
770
– – ﹤0.01% 798
2020
Q2 		$3K Hold
770
– – ﹤0.01% 987
2020
Q1 		$4K Buy
+770
New +$3.15K ﹤0.01% 916

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Winslow Evans & Crocker's PACB Position: Q4 2020 in Review

Winslow Evans & Crocker held its Pacific Biosciences (PACB) position steady in Q4 2020 at 770 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

Winslow Evans & Crocker first reported a position in PACB in Q1 2020 and has held it in 4 quarters since. 210 funds tracked by Wall St. Rank hold PACB as of Q4 2020.

  • Winslow Evans & Crocker held 770 shares of Pacific Biosciences worth $20K as of Q4 2020.
  • Winslow Evans & Crocker left its Pacific Biosciences share count unchanged in Q4 2020.
  • Pacific Biosciences made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #790 holding.
  • Winslow Evans & Crocker first reported a position in Pacific Biosciences in Q1 2020 and has held it in 4 quarters since.
  • 210 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.